Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Nexalin Technology Inc

NXL ✓ COMPLIANT ☆ Track — members

Nasdaq · Healthcare · Advanced Medical Equipment & Technology ·

USA Micro Cap Analyst: BUY

Last Close

$0.35

▼ -0.11%

Market Cap $7.71M · Vol 5.82K

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$7.71M

Micro Cap

Div Yield

N/A

EPS Growth

+24.30%

YoY

RSI (14)

32.47

Momentum

Beta

3.95

vs Market

52W High

$2.00

82.50% below

52W Low

$0.31

13.49% above

Volume

5.82K

Avg 26.69K

P/B

2.86

Price-to-book

ROE

N/A

Return on equity

Free Float

89.51%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Nexalin Technology Inc (NXL) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does NXL pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

-0.82%

-14.65%

+2.94%

-22.67%

YTD

-37.28%

-56.53%

-42.72%

N/A

Financials & Valuation

TTM · Annual

Total Revenue	$301.65K
Net Income	$-8,222,180.00
Revenue Growth (YoY)	-82.77%
Gross Margin	79.65%
Operating Margin	-2,781.69%
Net Profit Margin	-2,725.76%
ROE	N/A
ROA · ROIC	-185.64% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	30.32
P/B	2.86
P/FCF	N/A
EPS Growth	+24.30%
Outstanding Shares	22.04M

Technical Indicators

50-Day SMA	$0.40
200-Day SMA	$0.58
RSI (14)	32.47
Beta	3.95
52-Week High	$2.00
52-Week Low	$0.31

Volume Today	5.82K
Avg Daily Volume (30D)	26.69K
Relative Volume	0.22x
Volatility (10D)	61.85
Volatility (30D)	122.51
Free Float	89.51%

Analyst Consensus

BUY

Current Price $0.35

Mean Target $2.00

52W Low$0.31 52W High$2.00

Current

Target

$0.31 $2.00

Current Analyst target

+471.43% upside potential · 1 analysts

Identifiers

ExchangeNasdaq

FIGIBBG014CRDHD1

ISINUS65345B2016

CountryUnited States of America

Sub-IndustryAdvanced Medical Equipment & Technology (NEC)

Earnings DateNov 25, 2026

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

TMO Thermo Fisher Scientific Inc -1.28% DHR Danaher Corp -0.71% ISRG Intuitive Surgical Inc -1.68% BSX Boston Scientific Corp +0.27% EW Edwards Lifesciences Corp -1.04%

Company Profile

Nexalin Technology, Inc. is a medical device company. It engaged in design and development of neurostimulation products for mental health epidemics. It has developed an easy-to-administer medical device (Generation 1 or Gen-1) that utilizes bioelectronic medical technology to treat anxiety, depression and insomnia, without the need for drugs or psychotherapy. Its original Gen-1 devices are cranial electrotherapy stimulation (CES) devices that emit a waveform at 4 milliamps during treatment. It has designed and developed a new advanced waveform technology to be emitted at 15 milliamps through new and improved medical devices referred to as (Generation 2 or Gen-2) and (Gen-3). Gen-2 is a clinical use device with a modern enclosure to emit the new 15 milliamp advanced waveform. Gen-3 is a new patient headset that will be prescribed by licensed medical professionals in a virtual clinic setting like existing telehealth platforms. It also operates PONM, which is a digital health platform.